Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2007 5
2008 1
2009 3
2010 1
2011 1
2012 3
2013 2
2014 1
2015 1
2016 1
2018 3
2019 3
2020 3
2021 4
2022 10
2023 5
2024 3
2025 5
2026 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

51 results

Results by year

Filters applied: . Clear all
Page 1
Targeting proteostasis in multiple myeloma through inhibition of LTK.
Våtsveen TK, Giliberto M, Bjornsdottir V, Centonze F, Besse A, Frey Y, Skånland SS, Tveita A, Alirezaylavasani A, Imbery JF, Misund K, Reiterer V, Zahoor M, Driessen C, Besse L, Tasken K, Schjesvold FH, Farhan H, Munthe LA. Våtsveen TK, et al. Among authors: skanland ss. Leukemia. 2025 Sep;39(9):2237-2245. doi: 10.1038/s41375-025-02682-8. Epub 2025 Jul 9. Leukemia. 2025. PMID: 40634511 Free PMC article.
Longitudinal omics data and preclinical treatment suggest the proteasome inhibitor carfilzomib as therapy for ibrutinib-resistant CLL.
Arseni L, Sigismondo G, Yazdanparast H, Hermansen JU, Mack N, Ohl S, Kalter V, Iskar M, Kalxdorf M, Friedel D, Rettel M, Paul Y, Ringshausen I, Eldering E, Dubois J, Kater AP, Zapatka M, Roessner PM, Tausch E, Stilgenbauer S, Dietrich S, Savitski MM, Skånland SS, Krijgsveld J, Lichter P, Seiffert M. Arseni L, et al. Among authors: skanland ss. Nat Commun. 2025 Jan 26;16(1):1041. doi: 10.1038/s41467-025-56318-7. Nat Commun. 2025. PMID: 39863584 Free PMC article.
PI3K Inhibitors in Hematology: When One Door Closes….
Skånland SS, Okkenhaug K, Davids MS. Skånland SS, et al. Clin Cancer Res. 2024 Sep 3;30(17):3667-3675. doi: 10.1158/1078-0432.CCR-24-0967. Clin Cancer Res. 2024. PMID: 38967552 Free PMC article. Review.
Kinase-impaired BTK mutations are susceptible to clinical-stage BTK and IKZF1/3 degrader NX-2127.
Montoya S, Bourcier J, Noviski M, Lu H, Thompson MC, Chirino A, Jahn J, Sondhi AK, Gajewski S, Tan YSM, Yung S, Urban A, Wang E, Han C, Mi X, Kim WJ, Sievers Q, Auger P, Bousquet H, Brathaban N, Bravo B, Gessner M, Guiducci C, Iuliano JN, Kane T, Mukerji R, Reddy PJ, Powers J, Sanchez Garcia de Los Rios M, Ye J, Barrientos Risso C, Tsai D, Pardo G, Notti RQ, Pardo A, Affer M, Nawaratne V, Totiger TM, Pena-Velasquez C, Rhodes JM, Zelenetz AD, Alencar A, Roeker LE, Mehta S, Garippa R, Linley A, Soni RK, Skånland SS, Brown RJ, Mato AR, Hansen GM, Abdel-Wahab O, Taylor J. Montoya S, et al. Among authors: skanland ss. Science. 2024 Feb 2;383(6682):eadi5798. doi: 10.1126/science.adi5798. Epub 2024 Feb 2. Science. 2024. PMID: 38301010 Free PMC article.
Clinical forecasting of acute myeloid leukemia using ex vivo drug-sensitivity profiling.
Andersen AN, Brodersen AM, Ayuda-Durán P, Piechaczyk L, Tadele DS, Baken L, Fredriksen J, Stoksflod M, Lenartova A, Fløisand Y, Skånland SS, Enserink JM. Andersen AN, et al. Among authors: skanland ss. Cell Rep Methods. 2023 Dec 18;3(12):100654. doi: 10.1016/j.crmeth.2023.100654. Epub 2023 Dec 7. Cell Rep Methods. 2023. PMID: 38065095 Free PMC article.
51 results